Company approved Q1 financial results with standalone net profit soaring to ₹15.11 Cr and consolidated to ₹11.06 Cr.

It boosted its stake in 7Med India to 41.23% for ₹19.26 Cr.

Two directors resigned; Dr. Ellen Jane Feehan is now Executive Director & CEO.

An ₹10.85 Cr impairment loss was noted from HHT investment.